PISANO, Calogera
 Distribuzione geografica
Continente #
NA - Nord America 7.321
AS - Asia 4.188
EU - Europa 3.633
Continente sconosciuto - Info sul continente non disponibili 806
SA - Sud America 767
AF - Africa 112
OC - Oceania 8
Totale 16.835
Nazione #
US - Stati Uniti d'America 7.091
SG - Singapore 1.596
RU - Federazione Russa 1.218
CN - Cina 1.072
IT - Italia 748
BR - Brasile 602
HK - Hong Kong 376
VN - Vietnam 335
FI - Finlandia 326
PL - Polonia 295
DE - Germania 275
BD - Bangladesh 231
FR - Francia 204
GB - Regno Unito 150
JP - Giappone 110
CA - Canada 97
IE - Irlanda 97
KR - Corea 87
UA - Ucraina 86
IN - India 85
AR - Argentina 48
MX - Messico 44
RO - Romania 43
SE - Svezia 43
NL - Olanda 40
TR - Turchia 40
IQ - Iraq 37
SA - Arabia Saudita 32
CO - Colombia 25
ID - Indonesia 25
ZA - Sudafrica 25
EC - Ecuador 24
PK - Pakistan 24
VE - Venezuela 24
ES - Italia 20
JM - Giamaica 20
AT - Austria 17
BE - Belgio 17
UZ - Uzbekistan 17
CI - Costa d'Avorio 16
CR - Costa Rica 16
KE - Kenya 16
MA - Marocco 15
NP - Nepal 15
MY - Malesia 12
PH - Filippine 12
PY - Paraguay 12
CL - Cile 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
HN - Honduras 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
JO - Giordania 9
AZ - Azerbaigian 8
IR - Iran 8
AU - Australia 7
DZ - Algeria 7
EU - Europa 7
GR - Grecia 6
MT - Malta 6
TN - Tunisia 6
AL - Albania 5
BG - Bulgaria 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
PE - Perù 5
PR - Porto Rico 5
PS - Palestinian Territory 5
BH - Bahrain 4
BY - Bielorussia 4
GE - Georgia 4
IL - Israele 4
LB - Libano 4
NG - Nigeria 4
OM - Oman 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
GY - Guiana 3
LT - Lituania 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BN - Brunei Darussalam 2
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
Totale 16.013
Città #
Singapore 1.119
Ashburn 895
San Jose 699
Fairfield 537
Hong Kong 368
Chandler 349
Council Bluffs 314
Woodbridge 290
Zgierz 278
Houston 250
Wilmington 239
Seattle 233
Moscow 191
Cambridge 188
Hefei 181
Ann Arbor 172
Santa Clara 168
Beijing 149
Palermo 136
Lauterbourg 123
Los Angeles 120
Tokyo 108
Dallas 101
Ho Chi Minh City 101
New York 99
Dublin 97
Hanoi 84
Helsinki 84
Medford 83
Des Moines 82
Rome 72
Buffalo 70
Boardman 57
São Paulo 57
Chicago 55
Dearborn 54
Milan 54
Altamura 50
Princeton 50
Frankfurt am Main 44
Guangzhou 44
Nanjing 44
The Dalles 44
San Diego 39
Jacksonville 38
Columbus 37
Nuremberg 36
Redondo Beach 36
Lawrence 34
London 32
Phoenix 32
Piscataway 27
Shenyang 27
Atlanta 25
Riyadh 23
Toronto 23
Montreal 22
Denver 20
Orem 19
Tulsa 19
Changsha 17
Munich 17
Abidjan 16
Bologna 16
Brussels 16
Lappeenranta 16
Belo Horizonte 15
Brooklyn 15
Chennai 15
Da Nang 15
Falls Church 15
Jinan 15
Mumbai 15
Nairobi 15
Rio de Janeiro 15
Tashkent 15
Haiphong 14
Nanchang 14
Paris 14
Salt Lake City 14
Seoul 14
Xi'an 14
Baghdad 13
Kingston 13
Ningbo 13
Brasília 12
Ludwigshafen am Rhein 12
Naples 12
San José 12
Tianjin 12
Curitiba 11
Hải Dương 11
Shanghai 11
Springfield 11
Warsaw 11
Ankara 10
Hebei 10
Jiaxing 10
Johannesburg 10
Miami 10
Totale 9.558
Nome #
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals? 278
Can the TLR-4-Mediated Signaling Pathway Be a Key Inflammatory Promoter for Sporadic TAA? 271
Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives 269
A particular phenotype of ascending aorta aneurysms as precursor of type A aortic dissection 263
OBTAINING MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE OR MURIN ORIGIN: EXPERIMENTAL STUDY. 249
Histological and genetic studies in patients with bicuspid aortic valve and ascending aorta complications 249
THE ROLE OF INFLAMMATION IN TYPE A AORTIC DISSECTION: A PILOT STUDY 247
Penn classification in acute aortic dissection patients 245
Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm 245
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 245
Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: A 4.8-year prospective cohort study 244
Identification of Three Particular Morphological Phenotypes in Sporadic Thoracic Aortic Aneurysm: Phenotype III As Sporadic Thoracic Aortic Aneurysm biomarker in Aged Individuals 236
Cardiovascular disease in ageing: An overview on thoracic aortic aneurysm as an emerging inflammatory disease 236
Is the mean blood leukocyte telomere length a predictor for sporadic thoracic aortic aneurysm? Data from a preliminary study 234
A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status? 227
Role of Matrix Metalloproteinases in complications of thoracic aortic aneurysm 225
Coronary artery fistulas: symptoms may not correlate to size. An emblematic case and literature review 225
Ascending aorta phenotypic and genotypic changes in bicuspid aortic valve disease 223
Early structural degeneration of Mitroflow aortic valve: Another issue in addition to the mismatch? 219
Impact of Prosthesis-Patient Mismatch after Mitral Valve Replacement 204
Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility. 203
Decellularized Saphena: Biologic Scaffold for 3D Cellular Growth 201
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. 197
Valve prosthesis-patient mismatch: hemodynamic, echocardiographic and clinical consequences 189
Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome 188
Regulation of PDE5 expression in human aorta and thoracic aortic aneurysms 185
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 184
Is the Serum N Terminal Pro-Brain Natriuretic Peptide the Best Candidate Biomarker for Long-term Prognosis in Patients with Prosthesis-patient Mismatch after Mitral Valve Replacement? 179
CAN THE AORTIC WALL COMMUNICATE WITH US? 177
Is the sporadic thoracic aneurysm the result of inflammatory process 177
Role of cachexia and fragility in the patient candidate for cardiac surgery 174
Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve vs tricuspid aortic valve patients: clinical implications of a pilot study 172
Biomechanical properties and histomorphometric features of aortic tissue in patients with or without bicuspid aortic valve 170
Vascular Aging effect on Medial aorta degeneration: focus on blood keukocyte telomere lenght in Hypertensive and old patients with sporadic thoracic aortic aneurysm 165
Can The Aortic Wall Comunicate With Us? 164
Red Blood Cell Distribution Width, Vascular Aging Biomarkers, and Endothelial Progenitor Cells for Predicting Vascular Aging and Diagnosing/Prognosing Age-Related Degenerative Arterial Diseases 161
Diagnostic and Prognostic Relevance of Red Blood Cell Distribution Width for Vascular Aging and Cardiovascular Diseases 160
Pathophysiological implications of inflammation and genetic inflammatory factors in hypertensive and old patients affected by sporadic thoracic aortic aneurysm 157
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide 156
Stem cells and new intervention measures as emerging therapy in cardiac surgery 152
TGF-B pathway polymorphisms as markers for gender differential susceptibility to sporadic thoracic aortic aneurysm 151
Immunohistochemical expression and apoptotic role of Caspase9 in aortic aneurysms 149
Notch 1 pathway and EPCs in bicuspid aortic valve: is their interplay involved in the ascending aortic aneurysm onset? 149
valve prosthesis-patient mismatch: hemodynamic, echocardiografic and clinical evidences 145
RED BLOOD CELL DISTRIBUTION WIDTH PREDICTS MORBIDITY AND MORTALITY AFTER AORTIC VALVE REPLACEMENT 128
A Narrative Review: Syndecans in Aortic Aneurysm Pathogenesis and Course—Biomarkers and Targets? 125
Hydrodynamic Alterations Produced by Subaortic Membranes: An in Vitro Study 124
Matrix Metalloproteinases (MMPs), Their Genetic Variants and miRNA in Mitral Valve Diseases: Potential Biomarker Tools and Targets for Personalized Treatments 124
Retention of temporary epicardial pacing wires: when migration causes dehiscence of a sternal wound 117
Type 5 phosphodiesterase (PDE5) and the vascular tree: From embryogenesis to aging and disease 113
Acute Myocardial Infarction Ten Days after Bentall Procedure due to Coronary Embolism: Etiology Discussion and Rare Case Presentation 113
Acute type A aortic dissection: Beyond the diameter 112
Polymorphisms of pro-inflammatory IL-6 and IL-1β cytokines in ascending aortic aneurysms as genetic modifiers and predictive and prognostic biomarkers 109
Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease 107
Role of the inducibile nitric oxide synthase in inflammatory pathogenesis of the ascending aortic aneurysm 106
Genotyping strategy of SMAD-3 rs3825977 gene variant for a differential management of ascending aorta aneurysm in women people: Gender oriented diagnostic tools 106
Oxidative Stress in the Pathogenesis of Aorta Diseases as a Source of Potential Biomarkers and Therapeutic Targets, with a Particular Focus on Ascending Aorta Aneurysms 105
Risk of aortic dissection in patients with ascending aorta aneurysm: a new biological, morphological, and biomechanical network behind the aortic diameter 102
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 100
1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study 100
Advantages of minimal access versus conventional aortic valve replacement in elderly or severely obese patients 100
Surgical "elephant trunk" arch replacement with a branched arch prosthesis: two alternative operative techniques 99
The Endothelial Transcription Factor ERG Mediates a Differential Role in the Aneurysmatic Ascending Aorta with Bicuspid or Tricuspid Aorta Valve: A Preliminary Study 97
Corrigendum to “CAR, mGPS and hs-mGPS: Which of these is the best gero-biomarker for age-related diseases? And for what clinical application?” [Mech. Aging Dev. 220 (2024) 111952] 97
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry 96
CAR, mGPS and hs-mGPS: What is among them the best gero-biomarker for age-related diseases? And for what clinical application? 96
The effect of preoperative respiratory physiotherapy and motor exercise in patients undergoing elective cardiac surgery: Short-term results 95
Mitral Valve Surgery by Means of Minimally Invasive Right Mini-Thoracotomy Compared with Standard Sternotomy: Technical Surgical Aspects, Clinical Results in the Current Era 90
Valve-in-Valve Transcatheter Aortic Valve Implantation Versus Redo SAVR for Degenerated Biological Prosthesis: A Narrative Review Stating Our Experience 90
Pulmonary artery aneurysm: case report and experience of our center 89
Imaging and monitoring in minimally invasive valve surgery using an intra-aortic occlusion device: A single center experience 88
A rare localization of papillary fibroelastoma 88
miRNA-Driven Regulation of Endothelial-to-Mesenchymal Transition Differs among Thoracic Aortic Aneurysms 88
Aspetti istomorfologici e genetici degli aneurismi 87
[Surgical and percutaneous treatment of hypertrophic obstructive cardiomyopathy: state-of-the-art review] 86
Casistica 86
The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery 85
The endoclamp device as a useful strategy during redo surgery on the aortic root and arch 85
A mathematical model to evaluate hemodynamic effects of the graft anastomosis in coronary surgery 84
miRNA Regulation of Cell Phenotype and Parietal Remodeling in Atherosclerotic and Non-Atherosclerotic Aortic Aneurysms: Differences and Similarities 84
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding 84
Alternative surgical approach to repairing a giant sinus of valsalva aneurysm 84
Analysis of the ice front propagation in heart tissues: First results 84
Clinical outcome and hemodynamic performance of st. Jude trifecta aortic prosthesis: Short-term follow-up and risk factors analysis 82
Bentall Operation: Early Surgical Results, Seven-Year Outcomes, and Risk Factors Analysis 82
CRT-723 Is the Sporadic Thoracic Aortic Aneurysm the Result of an Inflammatory Process? 82
Warm blood versus St. Thomas cardioplegia for myocardial protection in patients undergoing coronary artery bypass grafting 81
Red blood cell distribution width predicts mortality after coronary artery bypass grafting 80
Biomarkers in Heart Failure: A Review and a Wish 79
Sutureless Aortic Prosthesis Valves versus Transcatheter Aortic Valve Implantation in Intermediate Risk Patients with Severe Aortic Stenosis: A Literature Review 78
The Role of the Patient-Prosthesis Mismatch after Aortic Valve Replacement: The Prognostic Significance 77
How Refined Surgical Technical Solutions Can Make Bentall Operation a Low-Risk Procedure: 20-Year Personal Experience at the “Root” of the Aortic Diseases—It Is Time to Change Surgical Guidelines 76
Marfan syndrome in children: correlation between musculoskeletal features and cardiac Z-score 75
The need for the STS Score risk stratification system for aortic root aneurysms surgery 74
Initial Surgical Strategy for the Treatment of Type A Acute Aortic Dissection: Does Proximal or Distal Extension of the Aortic Resection Influence the Outcomes? 73
Anaortic off-pump coronary artery surgery as a primary strategy to reduce the risk of neurological complications 73
The benefit of a preoperative respiratory protocol and musculoskeletal exercise in patients undergoing cardiac surgery 73
Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population: Final Results from the OBSERVANT Study 72
miR-632 Induces DNAJB6 Inhibition Stimulating Endothelial-to-Mesenchymal Transition and Fibrosis in Marfan Syndrome Aortopathy 71
Cerebrovascular events after cardiovascular surgery: diagnosis, management and prevention strategies 71
Totale 14.091
Categoria #
all - tutte 64.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022497 0 0 32 19 24 33 36 45 82 65 39 122
2022/2023940 105 162 28 104 96 143 60 78 106 1 47 10
2023/20241.063 19 57 12 34 27 70 34 89 5 400 202 114
2024/20252.431 93 273 214 177 76 84 151 116 212 228 288 519
2025/20267.587 525 209 648 564 592 989 1.165 778 621 625 419 452
2026/2027947 391 225 331 0 0 0 0 0 0 0 0 0
Totale 16.835